Clinical Trials | April 14, 2026
AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
Highlights Mirvetuximab-based regimen promise
Highlights Mirvetuximab-based regimen promise
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
The results were consistent across both the 10 mg and 40 mg treatment arms
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
